Nephrology News
Fatigue Tied With Sorafenib, Sunitinib Use in Renal Cell Carcinoma
Although TKIs improve outcomes, they are still associated with toxicities common with cancer therapies, such as fatigue.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/